INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
115 hedge funds and large institutions have $2.76B invested in Infinity Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 30
Holders
115
Holding in Top 10
–
Calls
$3.19M
Puts
$1.38M
Top Buyers
| 1 | +$1.34B | |
| 2 | +$10M | |
| 3 | +$7.92M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$7.45M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.86M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$12.9M | |
| 3 | -$5.65M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$4.99M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$3.54M |